Learning Objectives

After participating in this activity, health care professionals should be able to

• Explain currently accepted management strategies for patients with metastatic malignant melanoma and relate how immunomodulatory agents fit into these strategies
• Summarize new agents and combination therapies for patients with malignant melanoma
• Identify characteristics that might make patients appropriate candidates for novel therapies
• Define how treatment options impact key quality of life issues for patients with malignant melanoma
• Describe patient management and education strategies for patients being treated for malignant melanoma

When choosing among continuing education activities, clinicians should select those that are appropriate for their educational needs. Participants in educational activities have the implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional effectiveness. Clinicians should reflect on this activity and its applicability to their own patient population, and then identify and implement appropriate practice changes.